Company profile for Santen Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Santen, we’re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future....
At Santen, we’re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a global company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka 530-8552
Telephone
Telephone
+81-6-6321-7000
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-13/santen-receives-uk-approval-for-ryjunea-low-dose-atropine-01-mgml-to-slow-progression-of-childhood-myopia

PHARMIWEB
13 Nov 2025

https://www.prnewswire.com/news-releases/remegen-and-santen-enter-into-exclusive-licensing-agreement-for-ophthalmic-innovative-drug-rc28-e-in-greater-china-and-asian-countries-302532212.html

PR NEWSWIRE
18 Aug 2025

https://www.globenewswire.com/news-release/2024/11/07/2976768/0/en/Clearside-Biomedical-Partner-Arctic-Vision-Executes-Commercial-Collaboration-Agreement-with-Santen-Pharmaceutical-Co-Ltd-for-ARVN001-Suprachoroidal-Space-Injection-Therapy-for-the-.html

GLOBENEWSWIRE
07 Nov 2024

https://www.globenewswire.com/news-release/2024/06/28/2906122/0/en/NurExone-s-ExoPTEN-Being-Studied-as-Glaucoma-Treatment-for-US-3-4-Billion-Market.html

GLOBENEWSWIRE
28 Jun 2024

https://www.businesswire.com/news/home/20230718106227/en

BUSINESSWIRE
18 Jul 2023

https://www.businesswire.com/news/home/20221006005295/en

BUSINESSWIRE
06 Oct 2022

ABOUT THIS PAGE

Contact Santen Pharmaceutical and get a quotation

Santen Pharmaceutical is a supplier offers 7 products (APIs, Excipients or Intermediates).

Find a price of Sennosides bulk with JDMF offered by Santen Pharmaceutical

Find a price of Bucillamine bulk offered by Santen Pharmaceutical

Find a price of Rivoglitazone Hydrochloride bulk offered by Santen Pharmaceutical

Find a price of Tiopronin bulk offered by Santen Pharmaceutical

Find a price of Tropicamide bulk offered by Santen Pharmaceutical

Find a price of MANUFACTURING PLANT AT NOTO, JAPAN bulk offered by Santen Pharmaceutical

Find a price of FACILITIES AND PROCEDURES IN TAMPERE, FINLAND bulk offered by Santen Pharmaceutical

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty